NCT06001385 HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05982106 To Evaluate the Effect of Food on the Pharmacokinetics of TQ05105 Tablets in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT05980806 A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia Status RECRUITING Phase PHASE2
NCT05972577 Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study Status COMPLETED Phase NA
NCT05665192 A Study to Assess Real-World Patient-Reported Outcomes With Fedratinib for Myelofibrosis Post-Ruxolitinib Status COMPLETED Phase N/A
NCT05582083 Managed Access Program for Momelotinib in Myelofibrosis Status NO_LONGER_AVAILABLE Phase N/A
NCT05535764 Allogeneic Hematopoietic Cell Transplantation With Pegylated Interferon Alfa-2a for Primary and Secondary Myelofibrosis Status RECRUITING Phase PHASE1
NCT05488548 Dual BET and CBP/p300 Inhibitor in Patients With Targeted Advanced Solid Tumors and Hematological Malignancies Status RECRUITING Phase PHASE1
NCT05455294 Combination Navitoclax, Venetoclax and Decitabine for Advanced Myeloid Neoplasms Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05447260 A New Prognostic Stratification-based Safety and Efficacy Study of Ruxolitinib in Myelofibrosis Status UNKNOWN Phase PHASE4
NCT05444972 A Study to Explore Treatment Patterns, Treatment Outcomes, Healthcare Resource Utilization in Adult Participants With Myelofibrosis Through Chart Review Status COMPLETED Phase N/A
NCT05410470 Efficacy and Safety of Ruxolitinib in Patients With Myelofibrosis Status COMPLETED Phase N/A
NCT05371964 A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis Status RECRUITING Phase PHASE1
NCT05320198 Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia Status RECRUITING Phase PHASE1/PHASE2